Unifi (UFI) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Jan, 2026Executive summary
Q4 FY24 saw sequential and year-over-year improvements in sales, profitability, and margins, with EBITDA reaching $5.9M and gross profit at $10.8M, driven by cost reductions, operational efficiencies, and market share gains in North America, Brazil, and Asia.
REPREVE Fiber products contributed 34% of Q4 sales, up from the prior quarter, and new products like Textile Takeback and ThermaLoop insulation were launched to drive future growth.
Profitability Improvement Plan and innovation initiatives are supporting margin recovery and positioning the business for growth in FY25 and FY26.
Inventory levels at retail and brand customers are near pre-pandemic norms, but restocking remains cautious amid sluggish consumer trends.
Net loss narrowed to $4.0M ($0.22/share) in Q4, with Adjusted EBITDA up from $1.7M in the prior year.
Financial highlights
Q4 FY24 consolidated net sales were $157.5M, up 6% sequentially and 4% year-over-year, with gross profit at $10.8M and gross margin at 6.9%.
Adjusted EBITDA reached $5.9M, a 100% increase from Q3 FY24, and Adjusted EPS improved to ($0.22), up 61.3% sequentially.
Brazil segment net sales grew 9% sequentially and nearly 19% year-over-year; Asia segment net sales rose 21% sequentially and over 17% year-over-year.
FY24 net sales were $582.2M, down from $623.5M in FY23, but gross profit improved to $16.6M from $14.2M.
Net debt at Q4 FY24 was $103.5M, up from $93.9M year-over-year; cash and cash equivalents at year-end were $26.8M.
Outlook and guidance
FY25 net sales are expected to grow over 10% from FY24, with significant improvements in gross profit, margin, and Adjusted EBITDA.
Q1 FY25 net sales guidance is $147M–$153M, with Adjusted EBITDA of $1M–$3M.
FY25 capex is forecasted at $10M–$12M.
Positive EBITDA is expected in every quarter of FY25.
Continued volatility in effective tax rate is anticipated.
Latest events from Unifi
- Q2 FY26 sales dropped 12.6%, but gross profit and cash flow improved on cost controls.UFI
Q2 20264 Feb 2026 - Net sales up 6.1% to $147.4M; gross profit and EBITDA rebounded, narrowing net loss.UFI
Q1 202517 Jan 2026 - Net loss widened to $16.8M on lower sales and restructuring, but Q4 improvement is expected.UFI
Q3 202523 Dec 2025 - Net sales up 1.4% YoY; margins pressured, but efficiency actions target future gains.UFI
Q2 20253 Dec 2025 - Shareholders will vote on directors, executive pay, incentive plan expansion, and auditor ratification.UFI
Proxy Filing2 Dec 2025 - Annual meeting to vote on directors, executive pay, auditor, with focus on governance and ESG.UFI
Proxy Filing2 Dec 2025 - Key votes include director elections, executive pay, incentive plan amendment, and auditor ratification.UFI
Proxy Filing2 Dec 2025 - Key votes include director elections, executive pay, and auditor ratification for 2025.UFI
Proxy Filing2 Dec 2025 - Sales and margins declined, but restructuring and innovation set up a 2026 recovery.UFI
Q4 202523 Nov 2025